Literature DB >> 9350399

Molecular aspects of neuro-oncology.

T Santarius1, M Kirsch, M L Rossi, P M Black.   

Abstract

Detailed understanding of molecular events responsible for brain tumor growth is a prerequisite for the development of effective therapeutic modalities leading to improved prognosis and cure. Advances in molecular biology in the past decades have revolutionized our understanding of cancer, including brain tumors. We have learned that abnormal proliferation, inability of the cells to die and their potential to modify their tissue environment result from accumulation of genetic aberrations. This article reviews genetic mechanisms implicated in the pathogenesis of nervous system tumors, such as unactivation of tumor suppressor and replication error genes, generation of abnormal growth factor loops, alterations of apoptotic pathways and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350399     DOI: 10.1016/s0303-8467(97)00025-5

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  2 in total

1.  Local interstitial delivery of z-butylidenephthalide by polymer wafers against malignant human gliomas.

Authors:  Horng-Jyh Harn; Shinn-Zong Lin; Po-Cheng Lin; Cyong-Yue Liu; Po-Yen Liu; Li-Fu Chang; Ssu-Yin Yen; Dean-Kuo Hsieh; Fu-Chen Liu; Dar-Fu Tai; Tzyy-Wen Chiou
Journal:  Neuro Oncol       Date:  2011-05-12       Impact factor: 12.300

2.  The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo.

Authors:  Nu-Man Tsai; Yi-Lin Chen; Chau-Chin Lee; Po-Chen Lin; Yeung-Leung Cheng; Wen-Liang Chang; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  J Neurochem       Date:  2006-09-20       Impact factor: 5.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.